<p>Mechanism of Sanguinarine in Inhibiting Macrophages to Promote Metastasis and Proliferation of Lung Cancer via Modulating the Exosomes in A549 Cells</p>-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Mechanism of Sanguinarine in Inhibiting Macrophages to Promote Metastasis and Proliferation of Lung Cancer via Modulating the Exosomes in A549 Cells

Published:2020-09 Issue: Volume:Volume 13 Page:8989-9003
ISSN:1178-6930
Container-title:OncoTargets and Therapy
language:en
Short-container-title:OTT

Author:

Yu Yuanyuan^ORCID,Luo Yingbin,Fang Zhihong,Teng Wenjing,Yu Yongchun,Tian Jianhui,Guo Peng^ORCID,Xu Rongzhong,Wu Jianchun^ORCID,Li Yan

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Oncology

Reference30 articles.

1. Exosomes play roles in sequential processes of tumor metastasis

2. CD97 promotes gastric cancer cell proliferation and invasion through exosome-mediated MAPK signaling pathway

3. Activation of Mesenchymal Stem Cells by Macrophages Prompts Human Gastric Cancer Growth through NF-κB Pathway

4. Exosomes Mediate Stromal Mobilization of Autocrine Wnt-PCP Signaling in Breast Cancer Cell Migration

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bioactivity and mechanism of action of sanguinarine and its derivatives in the past 10 years;Biomedicine & Pharmacotherapy;2024-04

2. Synergistic Activity and Mechanism of Sanguinarine with Polymyxin B against Gram-Negative Bacterial Infections;Pharmaceutics;2024-01-03

3. The role of tumor-associated macrophages in lung cancer: From mechanism to small molecule therapy;Biomedicine & Pharmacotherapy;2024-01

4. Insights into the potential of Sanguinarine as a promising therapeutic option for breast cancer;Biochemical Pharmacology;2023-06

5. Exosomal microRNAs from Mesenchymal Stem Cells: Novel Therapeutic Effect in Wound Healing;Tissue Engineering and Regenerative Medicine;2023-05-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3